Hatteras Venture Partners


Hatteras Venture Partners is a venture capital firm dedicated to building transformational human medicine companies that benefit patients and the professionals who serve them. With over two decades of experience, Hatteras focuses on early-stage investments in healthcare innovation, including biopharmaceuticals, medical devices, diagnostics, and healthcare IT. The firm is committed to improving health through transformative therapies and disruptive technologies.

Hatteras Venture Partners

Hatteras Venture Partners


Portfolio

Focused on developing a versatile epigenetic editing platform.

#Biopharma

Developing an extracardiac, extravascular approach to cardiac pacing and defibrillation.

#Med Devices

Delivers improved health outcomes, member experience, and cost savings with Advance Care Planning solutions.

#Healthcare IT

Focused on AAV gene therapy to reverse or prevent blindness.

#Biopharma

Developing engineered viral vectors for gene therapy using structure-inspired design of AAV vectors.

#Biopharma

Developing small-molecule therapies to address significant unmet needs in oncology.

#Biopharma